Retraction
Pharmacological agents in development for diabetic macular edema
Paper Information
Record ID:
24904
Author(s):
Publication Date:
July 08, 2020
Retraction Date:
December 07, 2020
(5.0 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Ophthalmology, University of Louisville, Louisville, KY, USA
- Byers Eye Institute, Stanford University, Palo Alto, CA 94303, USA
- Department of Ophthalmology, Ege University School of Medicine, Izmir, Turkey
- Advanced Eye Centre, Department of Ophthalmology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
- Ocular Imaging Research and Reading Center (OIRRC), Sunnyvale, CA, USA
Countries:
Article Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (10)
10
Total Citations8
Post-Retraction(80.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
3
After 2+ years
1575
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Effectiveness of aflibercept, ranibizumab, and Ozurdex for treating diabetic macular edema showing a suboptimal response: A comparative observational study
Otzem Chassid, Karine Beiruti Wiegler, Adam E Bashir et al. (7 authors)
Taiwan Journal of Ophthalmology
Open Access
Published: Mar 2025
1575 days after retraction
Oral Chinese medicines for treating diabetic macular edema: Protocol for a systematic search of randomized studies and meta-analysis
Miaoran Gao, Sheng Huang, Jian Zhou et al. (9 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2023
852 days after retraction
The neurovasculature as a target in temporal lobe epilepsy
Yvonne Reiss, Sebastian Bauer, Bastian David et al. (13 authors)
Brain Pathology
Open Access
Published: Jan 2023
28 citations
28 citations
758 days after retraction
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
Yawara Kikuchi, Yoshimi Odashima, Kazuhiro Yoshikawa et al. (8 authors)
BMC Nephrology
Open Access
Published: Oct 2022
3 citations
3 citations
691 days after retraction
Pharmacotherapy of diabetic retinopathy
Philip J. Luthert
Elsevier eBooks
Published: Jan 2022
390 days after retraction
Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta‐analysis
Samuel A. Minaker, Ryan H. Mason, Gabriela Lahaie Luna et al. (8 authors)
Acta Ophthalmologica
Open Access
Published: May 2021
21 citations
21 citations
148 days after retraction
Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology
María Lina Formica, Hamoudi Ghassan Awde Alfonso, Santiago Daniel Palma
Pharmacology Research & Perspectives
Open Access
Published: Mar 2021
42 citations
42 citations
93 days after retraction
New Insights in Resistant Diabetic Macular Edema
Dante Akira Kondo Kuroiwa, Fernando Korn Malerbi, Caio V. Regatieri
Ophthalmologica
Open Access
Published: Jan 2021
33 citations
33 citations
25 days after retraction
Retraction Note to: Pharmacological agents in development for diabetic macular edema
Mohammad Ali Sadiq, Muhammad Sohail Halim, Muha mmad Hassan et al. (10 authors)
International Journal of Retina and Vitreous
Open Access
Published: Dec 2020
6 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
5.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025